Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
LCCCR Lakeshore reports quiet quarter as acquisition vehicle evaluates targets amid SPAC sector headwinds KMT Kennametal Inc posts Q1 2026 earnings beat shares edge higher despite slight year over year revenue decline CIBC CM Stock Investment Risk vs Reward Q1 2026 EPS Exceeds Expectations Biotech and Pharma Stocks Slide as Capital Rotates Toward Energy Sector Top Economic Forecasters Project Inflation Rate to Reach 6 in Current Quarter Should You Sell Ethan ETD After 074 Drop 20260515 USChina Trade Thaw Xi and Trump Agree to Lower Some Tariffs to Boost Commerce SpaceXs IPO Prospects Highlight Heavy Reliance on Starlink for Growth and Profit Stan Lees AI Voice Revival ElevenLabs Deal Brings Marvel Legend Back to Life King Yuan Electronics Expands Global Presence with New Singapore Facility Targeting 300 Jobs ECB Rate Path May Deepen Stagflation Risks Berenberg Economist Warns SP 500 Inches Higher as Healthcare and Tech Lead Communication Services Slips Gen Z Bargain Hunters Drive Gains for Discount Retailers Walmart and Ross TPCS Q1 2026 Earnings Net Loss Reported Amid Limited Disclosures ThredUp TDUP Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Response Crescent Capital BDC Inc CCAP Q1 2026 Earnings Slight Earnings Miss Amidst Stable Portfolio Performance UAVS Q3 2023 Earnings Narrowing Losses and Market Optimism Amid Strategic Pivot NEWP Q1 2026 Earnings Widerthanexpected loss highlights exploration spending pressures American Express Q1 2026 Earnings EPS Surpasses Estimates at 428 Stock Edges Higher Veritone VERI Edges Higher as Stock Consolidates Near Key Support DigitalOcean Holdings DOCN Holds Steady Near Support as Traders Eye Resistance Disney DIS Edges Higher as Traders Eye Key Resistance Zone Blackrock MuniHoldings New Jersey Quality Fund MUJ Edges Higher as TaxFree Income Draws Steady Demand Fulcrum Therapeutics FULC Steadies Near 657 as Biotech Sector Waits for Catalyst